Guaifenesin

Manufacturer
Family Dollar, Inc. | Aurohealth LLC | Aurobindo Pharma Limited
Effective date
2022-10-29
Label type
Human OTC Drug Label
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 21:50:18

Label at a glance#

ProductGuaifenesin
Active ingredientGUAIFENESIN
Label structure13 sections

Indications and uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Dosage and administration

do not crush, chew, or break tablet take with a full glass of water this product can be administered without regard for the timing of meals adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours. children under 12 years of age: do not use

Storage and handling

store between 20° to 25°C (68° to 77°F) Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

(in each extended-release tablet)

Guaifenesin USP 1200 mg

Purpose

OTC - PURPOSE SECTION

Expectorant

Uses

INDICATIONS & USAGE SECTION


  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

WARNINGS SECTION


Do not use

  • for children under 12 years of age

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION


  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

OTC - STOP USE SECTION


  • cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION


ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

  • do not crush, chew, or break tablet
  • take with a full glass of water
  • this product can be administered without regard for the timing of meals
  • adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
  • children under 12 years of age: do not use

Other information

STORAGE AND HANDLING SECTION

  • store between 20° to 25°C (68° to 77°F)
  • Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing

Inactive ingredients

INACTIVE INGREDIENT SECTION


colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, pregelatinised starch (maize)

Questions?

OTC - QUESTIONS SECTION

1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST) You may also report side effects to this phone number.


DISTRIBUTED BY:
MIDWOOD BRANDS, LLC
500 VOLVO PARKWAY, CHESAPEAKE,
VA 23320

Code: AP/DRUGS/04/2016

Made in India

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (7 (1 x 7) Tablets)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

COMPARE TO THE ACTIVE INGREDIENT
IN MAXIMUM STRENGTH MUCINEX®*

NDC 55319-902-64

FAMILY
Wellness™

MAXIMUM STRENGTH
Mucus Relief
GUAIFENESIN EXTENDED-RELEASE TABLETS
1200 mg, EXPECTORANT


12                                69
HOUR                 ACTUAL SIZE

√    RELIEVES CHEST CONGESTION

√    THINS AND LOOSENS MUCUS

7 EXTENDED-RELEASE TABLETS


PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (7 (1 x 7) Tablets)
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1200 mg Blister Carton (7 (1 x 7) Tablets)

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55319-90255319-902-64

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210453-001GUAIFENESINGUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21
A210453-002GUAIFENESINGUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2184e616aacf4f…
2026-09-14 22:38:342026-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2184e616aacf4f…
2026-08-18 06:07:402026-07A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21caaa826d4ba7…
2026-08-18 06:07:402026-07A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-212680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21d06236e962d9…
2024-10-29 15:01 UTC2024-10A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-21301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-21301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-211e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-211e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-218072bd15b7f6…
2024-05-31 18:47 UTC2024-05A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-218072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-215d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-215d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-214b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-214b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A210453-001GUAIFENESIN600MGTABLET, EXTENDED RELEASE / ORAL2019-10-2174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A210453-002GUAIFENESIN1.2GMTABLET, EXTENDED RELEASE / ORAL2019-10-2174a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d1d68162-cef0-4ca1-9393-97e0db363d97ffb01058-d8b3-4c37-a8bb-bf0302364eb52022-10-29WarningsExact identifier
spl id: d1d68162-cef0-4ca1-9393-97e0db363d97
spl set id: ffb01058-d8b3-4c37-a8bb-bf0302364eb5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.